Cryo Cell International (CCEL) Net Cash Flow (2010 - 2026)

Cryo Cell International has disclosed Net Cash Flow across 17 years of filings, most recently posting -$69359.0 for Q1 2026.

• In Q1 2026, Net Cash Flow rose 79.47% year-over-year to -$69359.0; the TTM figure through Feb 2026 stood at $26550.0 (up 210.67% YoY), while the FY2025 annual figure was -$241929.0, down 256.19% from the prior year.
• Net Cash Flow retreated to -$69359.0 in Q1 2026, from $53824.0 in the prior quarter.
• Over the last five years, Net Cash Flow for CCEL reached as high as $659821.0 in Q2 2022 and fell as low as -$6.1 million in Q1 2022.
• The 5-year median for Net Cash Flow is -$158955.0 (2024), against an average of -$471377.4.
• Annual changes were most pronounced in 2022 — Net Cash Flow plunged 767.45% — and 2024, when it jumped 304.31%.
• A 5-year view of Net Cash Flow shows it stood at -$1.2 million in 2022, then surged by 85.42% to -$177929.0 in 2023, then jumped by 304.31% to $363523.0 in 2024, then slumped by 85.19% to $53824.0 in 2025, then tumbled by 228.86% to -$69359.0 in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$69359.0, $53824.0, and $127716.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.